Clinical trial
Investigation of the Effect of the Atherogenic Index on the Therapeutic Response to Tadalafil in Patients With Vascular Erectile Dysfunction
NCT07479901 is registered in ClinicalTrials.gov with Taksim Egitim ve Arastirma Hastanesi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Effect of the Atherogenic Index on the Therapeutic Response to Tadalafil in Patients With Vascular Erectile Dysfunction
- Lead sponsor
- Taksim Egitim ve Arastirma Hastanesi
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 21, 2025
- Completion date
- February 21, 2026
- Enrollment
- 176 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.